搜尋結果
Ozempic Maker Novo Nordisk Beats Profit Forecasts Amid Weight Loss Drug Frenzy
Forbes· 21 小時前Danish pharma giant Novo Nordisk raised its 2024 outlook and beat profit expectations in its first-quarter earnings Thursday ...
Here's a point-by-point rundown on why we're buying more of 3 portfolio stocks
CNBC· 10 小時前... Jim Cramer's Charitable Trust will own: 840 shares of SWK, increasing its weighting ...
The Best Walking Shoes For Flat Feet, According To A Podiatrist
Forbes· 21 小時前The best walking shoes for flat feet evenly redistribute your body weight to alleviate stress on your ...
Amgen investors await weight-loss drug data
Reuters· 2 日前, opens new tab investors eyeing dramatic share price gains for rivals with successful obesity ...
Novo Trades at Hefty Discount to Lilly Even After 350% Rally
Bloomberg· 13 小時前... A/S’s more than 350% rally over the past four years may have further to run if the weight ...
Losing Weight Is No Joke When You Have Long Covid
Bloomberg· 3 日前... where I recently bought a bathroom scale to help me figure out how to lose the weight& ... ...
Karen Firestone: Tech dominates the S&P 500. It's time to ask whether it's the best ...
CNBC· 3 日前For many decades, the key professional goal of many in the investment management industry has ...
The 17 Best Nightstands To Match All Décor Styles
Forbes· 3 日前The best nightstands provide plenty of space for all your bedtime essentials, plus other ...
Can Ozempic Maker Novo Nordisk Keep Up Its Momentum? - What’s News - WSJ Podcasts
The Wall Street Journal· 16 小時前Emily Field: This morning, Novo talked about a quadrupling of new patients starting Wegovy on a weekly basis in the United ...
What Social Media May Not Tell You About Weight-Loss Drugs - Tech News Briefing - WSJ Podcasts ...
The Wall Street Journal· 7 日前Coming up on today's show, a hack into healthcare technology company Change Healthcare has ...